相关实验视频
Updated: Jun 13, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
RBM39通过EZH2-介导的WNT7B/β-catenin通路增强胆管癌的生长
Nianli Liu1, Jinqiang Zhang2, Weina Chen2
1Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
RNA结合基因蛋白39 (RBM39) 通过调节EZH2剪接来驱动胆管癌 (CCA) 的生长. 抑制RBM39和EZH2均为CCA治疗提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- RNA结合动机蛋白39 (RBM39) 与各种癌症有关,但其在胆管癌 (CCA) 中的作用尚不清楚.
- 在CCA中研究RBM39对于了解其致癌功能和作为治疗点的潜力至关重要.
研究的目的:
- 为了阐明RBM39在胆管癌 (CCA) 中的功能.
- 探索RBM39作为CCA的潜在治疗点.
主要方法:
- 在人类CCA组织中分析了RBM39的表达.
- 利用CRISPR/Cas9和shRNA在体外和体内耗尽RBM39.
- 评估了RBM39抑制剂 (Indisulam) 和EZH2降解剂 (MS177) 的联合抗瘤作用.
主要成果:
- 在CCA中,RBM39的表达率升高,与预后不佳有关.
- 减少RBM39抑制了CCA细胞的增殖和瘤的生长.
- RBM39通过mRNA拼接调节EZH2表达,影响WNT7B/β-catenin信号传递.
结论:
- 一个新的RBM39-EZH2-β-catenin信号轴被确定为CCA进展的关键.
- 联合抑制RBM39和EZH2显示出协同的抗瘤活性,为CCA提供了潜在的治疗策略.
更多相关视频
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Non-Canonical Wnt Signaling Pathways
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...